Anti-HIV Drug Development: Structural Features and Limitations of Present Day Drugs and Future Challenges in the Successful HIV/AIDS Treatment

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|19|10|1767-1783

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.19, Iss.10, 2013-03, pp. : 1767-1783

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anti-HIV Drug Development - An Overview

By  

Current Pharmaceutical Design, Vol. 10, Iss. 32, 2004-12 ,pp. : 4005-4037

Bentham Science Publishers

Access to resources Recommend Favorite

Drug prices affect access to HIV/AIDS drugs

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 398, 2003-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Emerging anti-HIV drugs

By De Clercq Erik  

Expert Opinion on Emerging Drugs, Vol. 10, Iss. 2, 2005-05 ,pp. : 241-274

Informa Healthcare

Access to resources Recommend Favorite

Etravirine for the treatment of HIV/AIDS

By Schrijvers Rik  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 8, 2013-06 ,pp. : 1087-1096

Informa Healthcare

Access to resources Recommend Favorite

Recent Developments in Drug Targets and Delivery of Anti-HIV Drugs

By  

Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 6, Iss. 2, 2006-06 ,pp. : 107-119

Bentham Science Publishers

Access to resources Recommend Favorite